universal influenza vaccine / J&J - LARVOL DELTA

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (clinicaltrials.gov) - P1/2 | N=170 | Completed | Sponsor: Janssen Vaccines & Prevention B.V. | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (clinicaltrials.gov) - P1/2 | N=170 | Active, not recruiting | Sponsor: Janssen Vaccines & Prevention B.V. | Trial primary completion date: Nov 2023 ➔ Aug 2024

Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (clinicaltrials.gov) - P1/2 | N=170 | Active, not recruiting | Sponsor: Janssen Vaccines & Prevention B.V. | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (clinicaltrials.gov) - P1/2 | N=170 | Recruiting | Sponsor: Janssen Vaccines & Prevention B.V. | Trial primary completion date: Mar 2024 ➔ Nov 2023

Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (clinicaltrials.gov) - P1/2 | N=170 | Recruiting | Sponsor: Janssen Vaccines & Prevention B.V.

New P1/2 trial • Infectious Disease • Influenza • Respiratory Diseases